Sofie Biosciences Acquires Zevacor Pharma

Culver City-based Sofie Biosciences has acquired Illinois-based Zevacor Pharma (formerly IBA Molecular North America), the company said this week. Financial details of the buy were not announced. Zevacor Pharma is a manufacturer and distributor PET imaging diagnostics and radio-therapeutics products. Sofie Biosciences is a developer of molecular imaging diagnostics and technologies based on Positron Emission Tomography (PET). Sofie is led by President and CEO Patrick Phelps.